Ergomed offers a combination of expert skills and excellent resources. Our experts in early development have extensive experience in clinical pharmacology and clinical trial design, development, and execution particularly in oncology and rare diseases where the standard approaches are not fit for purpose.

We also partner with top investigators in some of the best phase I units in Europe and North America. This combination allows us to anticipate and remove any factors that could impact your early stage development.

Proving the efficacy of a medicine in Phase II clinical trials is an extremely sensitive part of drug development.

Management of Phase II trials requires highly experienced people who are able to identify potential challenges, mitigate risks, engage top investigators, recruit the right patients, and design a trial that will truly evaluate your candidate.

Late-stage clinical trials require both know-how and an extensive network. Our teams regularly navigate the challenges of recruiting huge patient populations whilst also meeting clinical standards and regulatory requirements.

They also regularly manage the complexities of Phase III trials, operating across multiple time zones, languages, cultures, and working environments.

Phase IV solutions ensure that your medicine’s full potential is recognized. With over 30 years of experience in this area, we have deep expertise across a wide range of therapeutic areas.

As Phase IV trials increasingly embrace advanced technologies, our teams have the experience to credibly establish evidence of value in real-world-settings.